| Serial Number | 85085203 |
| Word Mark | LEADERSHIP IN NANOPHARMACEUTICALS |
| Filing Date | Thursday, July 15, 2010 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 17, 2014 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 14, 2010 |
| Disclaimer with Predetermined Text | "NANOPHARMACEUTICALS" |
| Goods and Services | diagnostic and prognostic preparations for clinical or medical laboratory use; diagnostic and prognostic reagents for identifying a disease or disorder and/or the progression of a disease or disorder |
| Goods and Services | Pharmaceutical preparations for use in the diagnosis and prognosis of oncological diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of pre-cancerous diseases or disorders; pharmaceutical preparations for use in the diagnosis and prognosis of malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of benign cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations, namely, drug delivery systems that contain compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain nanometer scale or nanometer size compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain polymer and/or lipid based compounds for controlled release of a wide range of pharmaceuticals; pharmaceutical preparations for use in the diagnosis and prognosis of oncological diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of pre-cancerous diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis and treatment of benign cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis and prognosis of malignant cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical |
| Pseudo Mark | LEADERSHIP IN NANO PHARMACEUTICALS |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 20, 2010 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 20, 2010 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cerulean Pharma Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Party Name | Cerulean Pharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Event Date | Event Description |
| Monday, March 17, 2014 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, March 17, 2014 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, August 9, 2013 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Thursday, August 8, 2013 | EXTENSION 5 GRANTED |
| Tuesday, July 9, 2013 | EXTENSION 5 FILED |
| Friday, August 2, 2013 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, July 9, 2013 | TEAS EXTENSION RECEIVED |
| Wednesday, January 30, 2013 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Tuesday, January 29, 2013 | EXTENSION 4 GRANTED |
| Thursday, January 10, 2013 | EXTENSION 4 FILED |
| Thursday, January 10, 2013 | TEAS EXTENSION RECEIVED |
| Wednesday, September 5, 2012 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Wednesday, September 5, 2012 | CORRECTED NOA MAILED |
| Tuesday, September 4, 2012 | EXTENSION 3 GRANTED |
| Tuesday, July 24, 2012 | EXTENSION 3 FILED |
| Tuesday, September 4, 2012 | DIVISIONAL PROCESSING COMPLETE |
| Tuesday, July 24, 2012 | DIVISIONAL REQUEST RECEIVED |
| Tuesday, July 24, 2012 | TEAS REQUEST TO DIVIDE RECEIVED |
| Tuesday, July 24, 2012 | TEAS EXTENSION RECEIVED |
| Wednesday, March 7, 2012 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Tuesday, March 6, 2012 | EXTENSION 2 GRANTED |
| Wednesday, February 8, 2012 | EXTENSION 2 FILED |
| Friday, March 2, 2012 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, February 8, 2012 | TEAS EXTENSION RECEIVED |
| Thursday, July 28, 2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
| Tuesday, July 26, 2011 | EXTENSION 1 GRANTED |
| Tuesday, July 26, 2011 | EXTENSION 1 FILED |
| Tuesday, July 26, 2011 | TEAS EXTENSION RECEIVED |
| Tuesday, February 8, 2011 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 14, 2010 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 24, 2010 | NOTICE OF PUBLICATION |
| Wednesday, November 10, 2010 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, November 10, 2010 | ASSIGNED TO LIE |
| Friday, October 29, 2010 | EXAMINER'S AMENDMENT MAILED |
| Thursday, October 28, 2010 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, October 28, 2010 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, October 28, 2010 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, October 28, 2010 | ASSIGNED TO EXAMINER |
| Wednesday, July 21, 2010 | NOTICE OF PSEUDO MARK MAILED |
| Tuesday, July 20, 2010 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, July 19, 2010 | NEW APPLICATION ENTERED IN TRAM |